Select Bibliography

Filter by any of these (after searching):

Thanarajasingam, Gita

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 15 items

Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials

Atkinson, Thomas M. , Dueck, Amylou C. , Satele, Daniel V. ... - - JAMA Oncol - 2020

Manuscript - Secondary - Primary - Health Outcomes - N0591

Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance)

Barton, Debra L. , Thanarajasingam, Gita , Sloan, Jeff A. ... - - Cancer - 2014

Manuscript - Primary - Primary - Symptom Inter - N08C3

Composite Grading Algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Basch, Ethan , Becker, Claus , Rogak, Lauren J. , Schrag, Deborah ... - - Clin Trials - 2021

Manuscript - Secondary-not-in-original - Primary - Health Outcomes - A091105

Development of a Composite Scoring Algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (Alliance)

Basch, Ethan , Becker, Claus , Rogak, Lauren , Spears, Patricia ... - ISOQOL - QUALITY OF LIFE RESEARCH - 2019

Abstract - Secondary-not-in-original - Primary - Health Outcomes - A091105

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

Basch, Ethan , Schrag, Deborah , Henson, Sydney , Jansen, Jennifer ... - - JAMA - 2022

Manuscript - Secondary - Primary - Health Outcomes - AFT-39

Digital symptom monitoring with patient-reported outcomes in community oncology practices: A U.S. national cluster randomized trial.

Basch, Ethan , Schrag, Deborah , Jansen, Jennifer , Henson, Sydney ... - ASCO PS - Nov - J Clin Oncol - 2021

Abstract - Primary - Primary - Health Outcomes - AFT-39

Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial

Basch, Ethan , Stover, Angela M. , Schrag, Deborah , Chung, Arlene ... - - JCO Clin Cancer Inform - 2020

Manuscript - Primary - Primary - CCDR - AFT-39

Composite Grading Algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Dueck, Amylou C. , Becker, Claus , Rogak, Lauren J. , Schrag, Deborah ... - ASCO - J Clin Oncol - 2020

Abstract - Secondary - Preliminary - Health Outcomes - A151925 , A091105 , COMET-2

Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2

Mazza, Gina L. , Petersen, Molly M. , Ginos, Brenda ... - - Qual Life Res - 2022

Manuscript - Primary - Primary - Health Outcomes - A151912 , A091105

Incorporating Clinicians’ CTCAE Grades as Auxiliary Variables When Imputing Patients’ PRO-CTCAE Scores via Multiple Imputation in Alliance A091105

Mazza, Gina L. , Petersen, Molly M. , Rogak, Lauren J. ... - ISOQOL - Quality of Life Research - 2020

Abstract - Secondary - Primary - Health Outcomes - A151925 , A091105

A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance)

Thanarajasingam, Gita , Atherton, Pamela J. , Novotny, Paul J. ... - - Lancet Oncol - 2016

Manuscript - Secondary-not-in-original - Primary - Health Outcomes - N9741 , NCCTG-97-92-54

Beyond maximum grade: A novel, longitudinal toxicity over time (ToxT) adverse event analysis of lenalidomide in follicular lymphoma in Alliance A151617

Thanarajasingam, Gita , Dueck, Amylou , Novotny, Paul J. ... - ICML - Hematol Oncol - 2017

Abstract - Primary - Primary - Health Outcomes - A151617 , CALGB-50401

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in CALGB 50401 (Alliance)

Thanarajasingam, Gita , Leonard, John P. , Witzig, Thomas E. ... - - Lancet Haematol - 2020

Manuscript - Primary - Primary - Health Outcomes - A151617 , CALGB-50401

Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non‐Small Cell Lung Cancer in CALGB 9730 (Alliance A151729)

Wong, Melisa L. , Gao, Junheng , Thanarajasingam, Gita ... - - Oncologist - 2021

Manuscript - Primary - Primary - Older Adult - A151729 , CALGB-9730

Comparison of chemotherapy toxicity over time according to age and performance status in patients with advanced non-small cell lung cancer: a toxicity over time analysis of CALGB 9730 (Alliance A151729)

Wong, Melisa L. , Gao, Junheng , Thanarajasingam, Gita ... - SIOG (ISOG) - J Geriatr Oncol - 2018

Abstract - Primary - Primary - Older Adult - CALGB-9730